Related Experiment Video
Updated: May 18, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Using HPV prevalence to predict cervical cancer incidence
Monisha Sharma1, Laia Bruni, Mireia Diaz
1Department of Health Policy and Management, Center for Health Decision Science, Harvard School of Public Health, Boston, MA 02115, USA. msharma04@gmail.com
Estimating cervical cancer (CC) burden is vital. A new model using human papilloma virus (HPV) prevalence in women aged 35-64 and geographic region accurately predicts CC incidence in countries lacking cancer registries.
Area of Science:
- Epidemiology
- Global Health
- Oncology
Background:
- Accurate cervical cancer (CC) burden data is crucial for resource allocation.
- Many countries lack essential cancer registries, hindering CC control efforts.
Purpose of the Study:
- To develop a prognostic model for estimating CC incidence in countries without cancer registries.
- To identify key predictors of CC incidence using human papilloma virus (HPV) prevalence and country-level factors.
Main Methods:
- Multivariate linear regression analysis was employed using data from 40 countries.
- Age-specific HPV prevalence in women (aged 35-64) and CC incidence rates were primary data points.
- Geographic region and country-level indicators were evaluated as additional predictors.
Main Results:
- CC incidence strongly correlated with HPV prevalence in women aged 35-64 (adjusted R-squared 0.41).
- Incorporating geographic region significantly improved prediction (adjusted R-squared 0.77); screening data did not add predictive value.
- HPV prevalence in older age groups was a better CC incidence predictor than in younger women.
Conclusions:
- A prognostic model utilizing HPV prevalence (women 35-64) and geographic region can effectively estimate CC incidence where registries are absent.
- Population-based HPV surveys in women over 35 are valuable for approximating CC risk in data-limited settings.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Cancer Prevention
Some...
Cancer Survival Analysis
